[The course of mucoviscidosis. Experience at Giens Center].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001999:Bronchoscopy / Q000009:adverse effects; D002701:Chloramphenicol / Q000009:adverse effects; D003550:Cystic Fibrosis; D003922:Diabetes Mellitus, Type 1 / Q000209:etiology; D006529:Hepatomegaly / Q000209:etiology; D006701:Home Nursing; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007239:Infections / Q000209:etiology; D008168:Lung / Q000000981:diagnostic imaging; D008171:Lung Diseases / Q000209:etiology; D009205:Myocarditis / Q000209:etiology; D010995:Pleural Diseases / Q000209:etiology; D011030:Pneumothorax / Q000209:etiology; D001261:Pulmonary Atelectasis / Q000209:etiology; D011656:Pulmonary Emphysema / Q000209:etiology; D011660:Pulmonary Heart Disease / Q000209:etiology; D011859:Radiography; D013203:Staphylococcal Infections / Q000209:etiology
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D002701:Chloramphenicol
L'évolution de la mucoviscidose. Expérience du centre de Giens.